BioTelemetry CEO: Cloud-Based Health | Mad Money | CNBC

Cohealo CEO: Health Care Sharing Economy | Mad Money | CNBCПодробнее

Mad Money - 10/22/24 | Audio OnlyПодробнее

Mad Money - 10/21/24 | Audio OnlyПодробнее

BioMarin Pharmaceutical CEO: Close to a Cure? | Mad Money | CNBCПодробнее

Core Laboratories CEO: The Oil Optimization Culprit | Mad Money | CNBCПодробнее

Alder Biopharmaceuticals CEO: Is The Tide Turning? | Mad Money | CNBCПодробнее

BioMarin CEO: Rare Treatments, High Costs | Mad Money | CNBCПодробнее

Cardinal Health CEO: Diagnosing the Future? | Mad Money | CNBCПодробнее

BioMarin Pharmaceutical CEO: Treating Hemophilia | Mad Money | CNBCПодробнее

Corbus Pharmaceuticals CEO: A Big Leap | Mad Money | CNBCПодробнее

BioMarin Pharmaceuticals CEO | Mad Money | CNBCПодробнее

Ingevity CEO: The Right Chemistry? | Mad Money | CNBCПодробнее

TG Therapeutics CEO: Cancer-Fighting Biotech | Mad Money | CNBCПодробнее

BionX Medical Technologies CEO: Transforming Movement | Mad Money | CNBCПодробнее

TherapeuticsMD Chairman & CEO: Redefining Women’s Health | Mad Money | CNBCПодробнее

Radius Health CEO Robert Ward: Biotech Bliss | Mad Money | CNBCПодробнее

BioMarin CEO: Biotech Breakthrough? | Mad Money | CNBCПодробнее

Radius Health CEO: Biotech Bliss Ahead? | Mad Money | CNBCПодробнее

Healthy Outlook?Подробнее